We screened 50 Korean traditional natural plants to measure the activation eŠect on choline acetyltransferase and attenuation of scopolamine-induced amnesia. The methanolic extracts from Zizyphus jujuba among the tested 50 plants, showed the highest activatory eŠect (34.1%) on choline acetyltransferase in vitro. By sequential fractionation of Zizyphus jujuba, the active component wasˆnally identiˆed as cis-9-octadecenoamide (oleamide). After isolation, oleamide showed a 65% activation eŠect. Administration of oleamide (0.32%) to mice signiˆcantly reversed the scopolamine-induced memory and W or cognitive impairment in the passive avoidance test and Y-maze test. Injection of scopolamine to mice impaired performance on the passive avoidance test (31% decrease in stepthrough latency), and on the Y-maze test (16% decrease in alternation behavior). In contrast, mice treated with oleamide before scopolamine injection were protected from these changes (12-25% decrease in step-through latency; 1-10% decrease in alternation behavior). These results suggest that oleamide should be a useful chemopreventive agent against Alzheimer's disease.
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Alzheimer's Disease (AD) is the most common cause of progressive cognitive dysfunction that aŠecting approximately four million Americans, causing more than 100000 deaths each year with a total annual cost approaching $70 billion.
1) The reduction of choline acetyltransferase (ChAT, EC 2.3.1.6) activity is related to the degree of dementia and the severity of neuropathological hallmarks of AD. ChAT activity was signiˆcantly lower in patients with AD than in age-matched control subjects in frontal cortex, temporal cortex, hippocampus, and cerebellum.
2) As the cognitive dysfunction and other features of AD are mediated by loss of function at cholinergic synapses in the neocortex and hippocampus, agents replacing lost cholinergic function should be useful in the management of this disease. 3) ChAT catalyzes the synthesis of acetylcholine (ACh) in cholinergic neurons. The enzyme is a singlestrand globular protein synthesized in the perikarion and transported to the nerve terminals probably by both slow and rapid axoplasmic ‰ow. 4) ChAT is present in a high abundance in the cytosol of cholinergic cell bodies. In nerve terminals, about 80-90z is present as a cytosolic protein, a portion of which may be ionically associated with synaptic membranes, whereas the remaining 10-20z of the total enzyme appears to be nonionically bound to the plasma membrane. 5) ChAT is also localized in the cell nucleus, but the mechanisms governing the subcellular distribution of ChAT have not been identiˆed, and the roles that diŠerent pools of the enzyme play in regulation of neurotransmitter biosynthesis remain unclear. In spite of the key role of ChAT in neurotransmission, the extremely low amounts and instability of the enzyme in the nervous tissues have limited its biochemical and structural analysis. 6) One strategy for ameliorating symptoms of AD is the restitution of near normal acetylcholine concentration in the synaptic cleft to improve cholinergic neurotransmission. ChAT activators increased synthesis of ACh to boost the endogenous level of ACh in the brain and thereby to boost cholinergic neurotransmission, resulting in the improvement of cognitive function in mild to moderate AD. In order toˆnd a natural active constituent that has a potent 
Materials and Methods
Materials. The dried plants were purchased from the Kyung-dong herbal market and ground enough to pass through aˆne screen (about 1 mm). All chemicals were purchased from Sigma.
Isolation of oleamide from Zizyphus jujuba. We screened 50 herbal spices in search for a choline acetyltransferase (ChAT) activator from natural resources. ChAT activators increase cholinergic transmission by improving the enzymatic synthesis of acetylcholine. Among these herbs, edible plants, and spices, the methanol extract from Zizyphus jujuba (1 kg) had the greatest eŠect on ChAT activity ( Table 1 ). The aqueous fraction and the chloroform fraction were obtained from the Zizyphus jujuba methanol extracts by agitation with a mixture of CHCl 3 :H 2 O (1:1). The chloroform fraction (5.72 g) of Zizyphus jujuba was put successively on aˆrst and second silica gel column (Merck, Darmstadt, Germany; 1 kg) with gradient elution with a mixture of solvents (CHCl3:MeOH) and a Sep-Pak cartridge (C 18 reverse phase; Waters). Analytical HPLC was done using a Waters 2690 pump and controller with a Waters 996 UV detector and Waters m-bondapack C18 reverse phase (3.9×150 mm) column. The data were controlled and analyzed using the Millenium Manager System (Version 2.15; Waters Associates). The data were collected over the range 190-800 nm and the detection was done at 252 nm. Injection of 10 ml was done automatically with a 100 ml injection loop onto a C18 column, with a 10 mm irregular particle size, using a reverse-phase HPLC column. Analytical separations were done at 0.5 ml W min using an 80-min linear gradient of 0-100z methanol. The structure of the resulting compound was analyzed by 1 H W 13 C-NMR (Avance DRX-600, Bruker Co., Germany) chemical shift and electron impact mass spectrometry (EI-MS: Hewlett-Packard 5890-JMS AX505WA, U.S.A.).
Cell culture. MC-IXC cells were cultured and maintained as previously described.
7) The cells, which are from a human neuroblastoma, were grown in Minimum Essential Medium (MEM) containing 15z fetal bovine serum (FBS). MC-IXC cells were grown in the presence of penicillin (100 U W ml) and streptomycin (0.1 mg W ml) at 379 C with 5z CO2. MC-IXC cells were passaged when the culture was 80-90z con‰uent. The cells were dislodged from the surface of the culture dish (100 mm) and dispersed into a single-cell suspension by repeated and forceful triturating of the culture medium directly onto the cells. The cells were subcultured once a week in the split ratio of 1:3 or 1:4.
Choline acetyltransferase activity measurement. Whole cellular extracts were prepared from MC-IXC cells. ChAT activity in MC-IXC cells was measured by a modiˆcation of the method of Fonnum.
8) For the enzyme source, MC-IXC cells were homogenized in a Glass-Col homogenizer (TERRE-HAUTE, USA) with 5 volumes of homogenizing buŠer [20 mM Tris-HCl (pH 7.2), containing 150 mM NaCl, 10 mM MgCl2, and 0.5z Triton X-100] 9 ) and centrifuged at 10,000 g-force for 30 min. The resulting supernatant was used as an enzyme source. All extraction steps were done at 49 C. The protein concentration was measured using the BCA kit (Bicinchoninic acid; Sigma Co., St. Louis, USA) with bovine serum albumin (BSA) as the protein standard. The enzymatic reaction contained 0.5z Triton X-100, 200 mM NaCl, 1 mM EDTA, 8 mM choline chloride, 0.1 mM eserine, and [
14 C] acetyl-CoA 5 mCi. The ACh formed was extracted with sodium tetraphenylborate in the assay. Radioactivity was measured in a Beckman scintillation counter.
Passive avoidance performance. The passive avoidance box was divided into two compartments, one illuminated and one dark, with a grid ‰oor. During the training trial, each mouse was placed in the lighted compartment; as soon as it entered the dark compartment, the door was closed and the mouse received an inescapable shock (0.5 mA, 1 sec). In the testing trial, given 1 day after the training trial, the mouse was again placed in the lighted compart- ment and the time until it re-entered the dark compartment was measured (the step-through latency maximum testing limit was 300 sec). The experimental procedures were approved by the guidelines of the Animal Care and Use Committee of Korea University.
Y-maze task. Recording spontaneous alternation behavior in a Y-maze assessed immediate working memory performance.
10) The Y-maze task was done on 4 weeks after oleamide administration. The maze was made of black-painted wood and each arm was 25 cm long, 14 cm high, and 5 cm wide and positioned at equal angles. Mice were placed at the end of one arm and allowed to move freely through the maze during an 8-min session. The series of arm entries was recorded visually and arm entry was considered to be complete when the hind paws of the mouse were placed completely in the arm. Alternation was deˆned as successive entries into the three arms on overlapping triplet sets. The percentage alternation was calculated as the ratio of actual to possible alternations (deˆned as the total number of arm entries minus two), multiplied by 100. The experimental procedures were approved by the guidelines of the Animal Care and Use Committee of the Korea University.
Statistical analysis. Data were expressed as mean± S.D. Statistical analysis was done by Student's t test using Sigma Plot software (Jandel Scientiˆc, California, U.S.A.).
Results and Discussion

EŠects of oleamide (cis-9-octadecenoamide) in Zizyphus jujuba on ChAT activity and Isolation of oleamide
We screened 50 Korean traditional natural plants to identify the activation eŠect s of choline acetyltransferase (data not shown). Among these plants, the methanol extract of the ground Zizyphus jujuba with activation eŠect on ChAT from MC-IXC cell was fractionated by chloroform. The chloroform fraction had the highest activation eŠect on ChAT activity ( Table 1 ). The chloroform fraction was chromatographed on theˆrst silica gel column yielding 18 new sub-fractions. Among them, No. 6-7 sub-fractions were shown to activate ChAT by more than 32z (Fig. 1) . No. 6-7 sub-fractions (90:10 and 80: 20) were further chromatographed on a second silica gel column, resulting in 33 new sub-fractions. Among the 33 frcations, No. 6 sub-fraction (third fraction of 90:10) had the highest activation eŠect on ChAT activity (Fig. 2) . The yield was 1.47 g. The fraction with the highest activation eŠect on ChAT from MC- Oleamide from Zizyphus jujuba activated ChAT in a dosedependent manner. The activation eŠects between oleamide from Zizyphus jujuba and cis-9-octadecenamide (oleamide) (SIGMA) were not diŠerent. The activation of enzyme activity was calculated as compared with the control value. Values represent the means (n＝3) ±S.D. Data were signiˆcantly diŠer-ent with P valuesº0.05 when compared with those of control. *cis-9-octadecenoamide (SIGMA) eŠect on ChAT.
IXC cells was put through preparative thin layer chromatography (TLC) (data not shown). Each band was monitored for ChAT activation eŠect. Between the activation eŠects of oleamide from Zizyphus jujuba and cis-9-octadecenamide (oleamide) (SIGMA) there was no diŠerence (Fig. 3) . This compound activated MC-IXC cell ChAT activity in a dose-dependent manner (Fig. 3) , conˆrming that it was the activator for ChAT in Zizyphus jujuba.
As shown in Fig. 3 , the active component had a single peak at about 252 nm. To identify the structure of this compound, 1 H W 13 C-NMR spectral analysis (Fig. 4.B.1, 2 ) and electron impact mass spectrometry (EI-MS) (Fig. 4.B. 3) were done. While low levels of the molecular ion of oleamide can be noted (m W z 281) the predominant fragment peaks were found at lower m W z (59, 72). The structure of oleamide has been reported 11) and we conˆrmed these results with cis-9-octadecenoamide (SIGMA). From these spectral data, the active component wasˆnally identiˆed as oleamide (cis-9-octadecenoamide). According to EI-MS, we conˆrmed that the molecular weight was 281 m W z (unit of mass spectrometry: mass to charge ratios).
EŠect of oleamide on scopolamine-induced memory impairment
Intraperitoneal injection of scopolamine hydrobromide, which is a muscarinic cholinergic receptor blocker, causes memory deˆcits and decreases cholinergic activity on behavioral performance, 12) therefore, this method of scopolamine exposure is a useful in vivo model for Alzheimer's disease. In this experiment, mice were treated with oleamide in the drinking water at various concentrations for up to 4 weeks before scopolamine administration. Because the average water intake per mouse per day was approximately 8-10 ml, the amount of oleamide consumed by mice receiving 0.16z oleamide in the drinking water ranged from 14 to 16 mg mouse -1 day -1 . All mice treated with oleamide gained body weight normally (39.3±1.2 g for control mice versus 37.8±1.4 g for mice treated with oleamide for 4 weeks) and did not show any signs of toxicity during the experiment (data not shown).
Then we tested the eŠects of oleamide on learning and memory in vivo using the scopolamine (SCOP)-induced amnesia model. 13) Treatment with SCOP (1 mg W kg), a muscarinic receptor blocker, signiˆcant-ly shortened the latency time (31z decrease in stepthrough latency) in the retention trial (Fig. 5) . However, treatment of mice with oleamide for 3 weeks attenuated the SCOP-induced impairment in a dose-dependent manner (12-25z decreases in stepthrough latency) with maximal eŠects observed at a concentration of 0.32z.
Spontaneous alternation behavior, which is regarded as a measure of spatial memory, 10) was investigated using the Y-maze test. Mice injected with SCOP displayed signiˆcantly impaired spatial working memory (16z decrease in alternation behavior). Pretreatment with oleamide blunted the SCOPinduced decrease in alternation behavior, with the greatest protection observed in mice pretreated for 3 weeks (Fig. 6A) . In contrast, the number of arm entries did not change among all the experimental groups, demonstrating that general locomotor activity was not aŠected by SCOP (Fig. 6B ). In the passive avoidance task and Y-maze task, we used cis-9-octadecenoamide (SIGMA) for comparative data and could not detect any diŠerences between oleamide from Zizyphus jujuba and cis-9-octadecenoamide from SIGMA (data not shown).
In this study, we have shown that oleamide (cis-9-octadecenoamide) of Zizyphus jujuba was puriˆed from natural edible plants. Oleamide has been reported to be isolated from the cerebrospinal ‰uid (CSF) of sleep-deprived cats, humans and rats, and shown to cause sleep in rats when injected intravascularly at nanomolar quantities. 14, 15) And oleamide was shown to potentiate 5-hydroxy-tryptamine actions at 5-HT2 receptors, which may in part explain its sleepinducing properties.
11) However, to our knowledge, this is theˆrst report that oleamide has an activation eŠect on ChAT. This low-molecular mass material could easily reach the site of action (brain) following oral or transdermal administration because the molecule could cross the blood-brain-barrier, the tight junction controlling the transport of material into the brain. 16) Thus this active component could slow down the decline of cognitive function and memory in some patients with mild or moderate Alzheimer's disease (AD). EŠects of oleamide on step-through latency (A) and retention percentage ( b) in the retention trial of the passive avoidance task. After injection of scopolamine (1 mg W kg), each behavioral test was done. Mice were trained on a one-trial step-through passive avoidance task. The testing trial was given 1 day after the training trial. The data are presented as means±S.D. mean (n＝ 10). Control mice were injected with 0.85z (w W v) saline (100 ml). *Pº0.05 vs saline-treated control. **Pº0.05 vs scopolamine alone. A pathologic hallmark of AD is the formation of senile plaques. 17) Amyloid-b peptide (A b), a 39-43 amino acid peptide, is a major component of these plaques. A b was shown to have the potential to induce oxidative stress and in‰ammation in the brain, 18) which are postulated to play important roles in the pathogenesis of AD. 19) An intracerebroventricular injection of low nanomolar doses of A b25-25 20) or A b1-28 21) impairs avoidance behavior and Y-maze alternation behavior in mice. Similarly continuous intracerebroventricular infusion of A b1-40 22) or A b1-42 23) induces learning and memory impairment in rats. In this study, we used a scopolamine-induced animal model as an experiment for A b-induced cholinergic impairment. Because scopolamine is a muscarinic cholinergic receptor blocker, it is frequently used to assess the eŠects of the cholinergic blockade on behavioral performance.
12) The results presented here were that 3 weeks administration of oleamide eŠectively protected against scopolamine-induced cholinergic toxicity, and furthermore, decrease of cortical acetylcholine levels results from A b-induced behavioral abnormality. 22) Therefore oleamide has both ChAT activator and A b-neurotoxicity blocking. In conclusion, oleamide from the natural plant may be a potential chemo-preventive agent against Alzheimer's disease.
